4/A
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-20-000637
CHIEF EXECUTIVE OFFICER gave up 2,590 shares (to pay taxes)
- CHIEF EXECUTIVE OFFICER acquired 7,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Williams Gregory C. CHIEF EXECUTIVE OFFICER | 2020-01-30 | Option exercise | +7,500 | 7,500 | D: show line 1 in the form | ||
| Williams Gregory C. CHIEF EXECUTIVE OFFICER | 2020-01-30 | Shares withheld for taxes | −2,590 | $3.91 | $10,127 | 4,910 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Williams Gregory C. CHIEF EXECUTIVE OFFICER | 2020-01-30 | Option exercise · Restricted Stock Units | −7,500 | 22,500 | D: show line 3 in the form |
Loading xslF345X03/form4a-03042020_020307.xml…